Susquehanna International Group, LLP Novo Nordisk A S Transaction History

Susquehanna International Group, LLP

$641 Billion
Q4 2024

A detailed history of Susquehanna International Group, LLP transactions in Novo Nordisk A S stock. As of the latest transaction made, Susquehanna International Group, LLP holds 285,708 shares of NVO stock, worth $17.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

285,708

Previous 889,702 67.89%

Holding current value

$17.1 Million

Previous $106 Million 76.8%

% of portfolio

0.0%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$85.0 - $120.04 $51.3 Million - $72.5 Million	-603,994 Reduced 67.89%	285,708 $24.6 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $64.4 Million - $78.7 Million	540,895 Added 155.07%	889,702 $106 Million
Q2 2024 Aug 15, 2024	SELL	$122.71 - $146.91 $89.2 Million - $107 Million	-726,875 Reduced 67.57%	348,807 $49.8 Million
Q1 2024 May 07, 2024	BUY	$102.11 - $135.92 $90.5 Million - $121 Million	886,667 Added 469.1%	1,075,682 $138 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $8.11 Million - $9.75 Million	92,442 Added 95.72%	189,015 $19.6 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $3.2 Million - $7.03 Million	35,233 Added 57.44%	96,573 $8.78 Million
Q2 2023 Aug 11, 2023	BUY	$155.98 - $172.65 $3.13 Million - $3.47 Million	20,097 Added 48.73%	61,340 $9.93 Million
Q1 2023 May 16, 2023	SELL	$132.34 - $159.14 $2.61 Million - $3.14 Million	-19,715 Reduced 32.34%	41,243 $6.56 Million
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $2.73 Million - $3.6 Million	-26,586 Reduced 30.37%	60,958 $8.25 Million
Q3 2022 Nov 14, 2022	SELL	$95.28 - $116.93 $70,221 - $86,177	-737 Reduced 0.83%	87,544 $8.72 Million
Q2 2022 Aug 15, 2022	SELL	$103.24 - $121.81 $28.1 Million - $33.2 Million	-272,284 Reduced 75.52%	88,281 $9.84 Million
Q1 2022 May 16, 2022	BUY	$93.1 - $112.54 $12.1 Million - $14.7 Million	130,309 Added 56.59%	360,565 $40 Million
Q4 2021 Feb 14, 2022	SELL	$95.88 - $117.08 $1.99 Million - $2.43 Million	-20,783 Reduced 8.28%	230,256 $25.8 Million
Q3 2021 Nov 15, 2021	BUY	$84.42 - $106.62 $670,885 - $847,309	7,947 Added 3.27%	251,039 $24.1 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $10.2 Million - $12.8 Million	151,190 Added 164.51%	243,092 $20.4 Million
Q1 2021 May 17, 2021	BUY	$67.06 - $75.82 $4.97 Million - $5.62 Million	74,077 Added 415.58%	91,902 $6.2 Million
Q4 2020 Feb 16, 2021	SELL	$63.89 - $73.8 $1.06 Million - $1.23 Million	-16,606 Reduced 48.23%	17,825 $1.25 Million
Q3 2020 Nov 16, 2020	SELL	$63.69 - $70.22 $2.01 Million - $2.21 Million	-31,483 Reduced 47.76%	34,431 $2.39 Million
Q2 2020 Aug 14, 2020	SELL	$58.54 - $67.94 $1.01 Million - $1.18 Million	-17,338 Reduced 20.83%	65,914 $4.32 Million
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $3.47 Million - $4.54 Million	70,112 Added 533.58%	83,252 $5.01 Million
Q4 2019 Feb 14, 2020	SELL	$49.86 - $58.26 $3.49 Million - $4.07 Million	-69,930 Reduced 84.18%	13,140 $761,000
Q3 2019 Nov 14, 2019	BUY	$47.54 - $53.43 $2.17 Million - $2.44 Million	45,591 Added 121.64%	83,070 $4.3 Million
Q2 2019 Aug 16, 2019	BUY	$46.79 - $52.47 $1.2 Million - $1.34 Million	25,541 Added 213.95%	37,479 $1.91 Million
Q2 2019 Aug 14, 2019	SELL	$46.79 - $52.47 $440,527 - $494,005	-9,415 Reduced 44.09%	11,938 $609,000
Q1 2019 May 15, 2019	SELL	$46.36 - $52.63 $3.48 Million - $3.96 Million	-75,172 Reduced 77.88%	21,353 $1.12 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $2.18 Million - $2.39 Million	46,547 Added 93.13%	96,525 $4.55 Million
Q1 2018 May 15, 2018	BUY	$48.49 - $58.14 $2.42 Million - $2.91 Million	49,978 New	49,978 $2.46 Million

Others Institutions Holding NVO

# of Institutions

1,861

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $135B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Novo Nordisk A S Transaction History